Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Evolutionary Relationships through Genome Comparisons

Evolutionary Relationships through Genome Comparisons

Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A 3'UTR polymorphism disrupts IRF2BP2 autoregulation through an eIF4H translational enhancer.

Frontiers in genetics·2026

Same author

Identification of a Novel Genetic Variant Responsible for Familial Atrial Fibrillation.

The Canadian journal of cardiology·2026

Same author

Genetic Risk Score Enables a Vaccine for Early Primary Prevention of CAD.

Methodist DeBakey cardiovascular journal·2025

Same author

A farewell editorial.

Current opinion in cardiology·2025

Same author

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2025

Same author

Identifying Structural Variants and Their Contribution to Cardiovascular Disease Risk: The Long and the Short of It.

Journal of the American Heart Association·2025

Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026

Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026

Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026

Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026

Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026

Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 24, 2026

Microbial Communities in Nature and Laboratory - Interview

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

Genomics: is it ready for primetime?

Sonny Dandona¹, Alexandre F R Stewart, Robert Roberts

¹Faculty of Medicine, McGill University, McIntyre Medical Building, 3655 promenade Sir William Osler Montreal, Quebec H3G 1Y6, Canada.

The Medical Clinics of North America

|March 7, 2012

Summary

This summary is machine-generated.

Researchers aim to uncover the genetic basis of coronary artery disease (CAD) by studying common and rare single nucleotide polymorphisms (SNPs). This will reveal new therapeutic targets and improve genetic risk prediction for CAD.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Published on: April 8, 2017

Related Experiment Videos

Last Updated: May 24, 2026

Microbial Communities in Nature and Laboratory - Interview

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Published on: April 8, 2017

Area of Science:

Genetics
Cardiovascular Medicine
Genomic Epidemiology

Background:

Coronary artery disease (CAD) heritability remains incompletely understood.
Identifying genetic factors is crucial for advancing cardiovascular medicine.
Current genetic studies have limitations in explaining the full genetic contribution to CAD.

Purpose of the Study:

To identify the missing heritability of coronary artery disease (CAD).
To investigate both common and rare single nucleotide polymorphisms (SNPs) associated with CAD.
To discover novel biological pathways and therapeutic targets for CAD.

Main Methods:

Comprehensive interrogation of common single nucleotide polymorphisms (SNPs).
Analysis of rare SNPs with significant biological effects.
Investigation of the underlying biological mechanisms linking genetic variations to CAD.

Main Results:

Focus on identifying common SNPs with modest effects and rare SNPs with profound effects.
Anticipation of discovering novel pathways through biological investigation.
Expectation of a more accurate assessment of genetic risk scoring for CAD.

Conclusions:

Understanding genetic variations is key to addressing the missing heritability of CAD.
Novel therapeutic targets may emerge from investigating CAD-associated pathways.
Improved genetic risk prediction models for CAD are anticipated.